Skip to main content

Goncalves Joana's Form 4 filing

Oruka Therapeutics, Inc. (ORKA) · filed May 15, 2026

Accession no.
0000907654-26-000039
Filed
May 15, 2026
Trade date
May 15, 2026
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $432.9K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Goncalves JoanaCIK 0001756991Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 15, 2026Common StockMOption exerciseAcquired+3,500$6.84+$23,94036,877Direct
May 15, 2026Common StockMOption exerciseAcquired+3,500$7.80+$27,30040,377Direct
May 15, 2026Common StockSSaleDisposed−4,800$61.56−$295,48835,577Direct
May 15, 2026Common StockSSaleDisposed−2,100$62.42−$131,08233,477Direct
May 15, 2026Common StockSSaleDisposed−100$63.52−$6,35233,377Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 15, 2026Common StockMOption exerciseDisposed−3,500$0.00$0207,563Direct
May 15, 2026Common StockMOption exerciseDisposed−3,500$0.00$0178,992Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)